High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy

SIMPLE SUMMARY: Tumor cells can evade destruction via immune cells by expressing coinhibitory membrane molecules, which suppress antitumoral immune responses. Immune checkpoint inhibitor therapy acts by blocking these inhibitory pathways. Although this type of immunotherapy has shown promising resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Riemann, Dagmar, Schütte, Wolfgang, Turzer, Steffi, Seliger, Barbara, Möller, Miriam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602055/
https://www.ncbi.nlm.nih.gov/pubmed/33066260
http://dx.doi.org/10.3390/cancers12102966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602055/
https://www.ncbi.nlm.nih.gov/pubmed/33066260
http://dx.doi.org/10.3390/cancers12102966

Ejemplares similares